Company profile: Applied BioCode
1.1 - Company Overview
Company description
- Provider of multiplex molecular diagnostic systems and panels for clinical testing, life science research, medicine, and AgBio. Offerings include the BioCode® MDx-3000 automated, high-throughput system and assays such as the BioCode® Gastrointestinal and Respiratory Pathogen Panels, BioCode® STI + Resistance Panel, BioCode® CoV-2 Flu Plus Assay, and BioCode® SARS-CoV-2 Assay.
Products and services
- BioCode® MDx-3000: An automated high-throughput molecular diagnostic system for multiplex testing used across clinical testing, life science research, medicine, and AgBio applications
- BioCode® Respiratory Pathogen Panel: A molecular-diagnostic panel that identifies respiratory pathogens for clinical testing and life science research using BioCode's multiplexing system
- BioCode® STI + Resistance Panel: A molecular-diagnostic panel that simultaneously detects sexually transmitted infections and associated resistance mutations for clinical testing and life science research using BioCode's multiplexing system
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Applied BioCode
Taconic Biosciences
HQ: United States
Website
- Description: Provider of animal models and related laboratory services for biomedical research, offering over 4,500 genetically engineered mouse and rat models, including repository models, standard strains, GEMs, and humanized immune system models. Services include custom model generation, colony management, FcResolv NOG-EXL superimmunodeficient mice, and the Wild Mouse Microbiome toolkit for drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Taconic Biosciences company profile →
Tessera Therapeutics
HQ: United States
Website
- Description: Provider of Gene Writing technology for permanent therapeutic alterations to the human genome, offering RNA Gene Writers to change base pairs, make small insertions, deletions or replacements, and integrate entire genes without double stranded breaks; DNA Gene Writers to durably write new DNA sequences with potential one-time cures; and a proprietary lipid nanoparticle delivery system for safe, effective nucleic acid delivery beyond the liver.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tessera Therapeutics company profile →
Xpand Biotech
HQ: The Netherlands
Website
- Description: Provider of bone repair and regeneration products based on proprietary surface science technology, with in-house R&D, manufacturing, and clean room facilities; based in Bilthoven, The Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xpand Biotech company profile →
Upfront Chromatography
HQ: Denmark
Website
- Description: Provider of customized protein separation processes and technologies for extraction and recovery of biotherapeutics, functional biomolecules, and macromolecular complexes. Denmark-based biotech with significant expertise and regulatory experience in developing and manufacturing customised industrial processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Upfront Chromatography company profile →
Torax Biosciences
HQ: United Kingdom
Website
- Description: Provider of innovative quality controls and IVD reagents for clinical laboratories, creating, developing, and producing these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Torax Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Applied BioCode
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Applied BioCode
2.2 - Growth funds investing in similar companies to Applied BioCode
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Applied BioCode
4.2 - Public trading comparable groups for Applied BioCode
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →